Immunic, Inc (IMUX) insider trading

Every open-market stock purchase and sale by Immunic, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Duane Nash (Chair), $16.7K, 16 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $7.48 on Oct 21, 2026.

Recent IMUX insider trades

DateInsiderTradeValue
Sep 16, 2026Robert Thorvald Nagel (Director)Bought (not open market)—
Sep 16, 2026Bvf Partners L P/il (Director)Bought (not open market)—
Aug 6, 2026Elena Ridloff (Director)Bought (not open market)—
Jul 5, 2026Joerg Neermann (Director)Bought (not open market)—
Jul 5, 2026Jon Congleton (Director)Bought (not open market)—
Jul 5, 2026Simona Skerjanec (Director)Bought (not open market)—
Jul 5, 2026Richard Alan Rudick (Director)Bought (not open market)—
Jul 5, 2026Barclay A Phillips (Director)Bought (not open market)—
Jun 29, 2026Richard Alan Rudick (Director)Bought (not open market)—
Jun 29, 2026Simona Skerjanec (Director)Bought (not open market)—
Jun 29, 2026Tamar D Howson (Director)Bought (not open market)—
Jun 29, 2026Michael W Bonney (Director)Bought (not open market)—
Jun 29, 2026Jon Congleton (Director)Bought (not open market)—
Jun 29, 2026Daniel Vitt (Director)Bought (not open market)—
Jun 29, 2026Glenn Whaley (CFO)Bought (not open market)—
Jun 29, 2026Jason Tardio (COO)Bought (not open market)—
Jun 29, 2026Barclay A Phillips (Director)Bought (not open market)—
Jun 29, 2026Joerg Neermann (Director)Bought (not open market)—
May 22, 2026Erik Lundgren (CEO)Bought (not open market)—
Apr 24, 2026Michael A. Panzara (C-suite exec)Bought (not open market)—

Who's trading IMUX

Get free alerts when an insider at Immunic, Inc files a new trade →